Veterinary/Animal Vaccines Market Report Competition by Manufacturers, Type and Application, Growth and Opportunities 2026
Download the Sample Report @ http://bit.ly/2IMv6aD
The rise in the incidences of zoonotic diseases are affecting humans and has led to increased interest in companion animal vaccines. Advancement in this area is mainly due to emergence of new zoonotic diseases, investment by government bodies and increased expenditures on animal health by pet lovers.
In recent years’ veterinary vaccines have made much impact on human health, welfare and production by developing novel vaccines which can target dangerous zoonotic diseases such as E. coli O157:H7, a food borne disease that can lead to HUS and kidney failure. Moreover, due to novel research in the field, expansion in the range of veterinary vaccines and formulations of adjuvants and reduction of pharmaceutical residuals in the human food chain will propel the growth of veterinary vaccines market. However, persistent economic slowdown, rising costs of storage and maintenance and the increase in the vegetarian population are major factors constituting to restraints of market. With improvement in costs, more investments in animal health and skilled expertise this market could have lucrative opportunities of growth.
The report segments the market on the basis of products, diseases, technologies and regions. On the basis of products market is categorized into companion animal vaccines, livestock, poultry, porcine, equine, aquaculture, and other animal vaccines. On the basis of technology, market is further segmented into inactivated vaccines, live attenuated vaccines, conjugate vaccines, toxoid vaccines, DNA vaccines, recombinant vaccines and subunit vaccines. In terms of disease, it is classified to livestock diseases, aquaculture, poultry, companion diseases and others. Geographically, the market is analyzed in North America, Europe, Asia-Pacific and LAMEA.
10% on Pre-Booking @ http://bit.ly/2ZjioHg
Many companies are working in development of veterinary vaccines by undergoing collaboration between research institutions and companies, product approvals and launches, licensing agreements and partnerships amongst companies and augmented R&D investment on veterinary vaccines for instance, Zoetis announces product approval in 2013 for Rui Lan An Swine Vaccine for curing highly pathogenic porcine reproductive and respiratory syndrome (HP PRRS). Moreover, Bayer and BioNTech AG entered into agreement in 2016 for development of mRNA vaccines and therapeutics particularly for animal health. Ceva Santé Animale acquired Biovac Laboratories in 2016 which is a leading manufacturer of autogenous vaccines. These advancements in veterinary vaccines sector are indicative of the future growth in market.
Some of the key players of the market are Bayer Healthcare, Zoetis (Pfizer), Boehringer Ingelheim, Bioniche Animal Health, Ceva, Elcano Animal Health, Heska Co., Merck Animal Health, Merial (Sanofi), and Virbac.
KEY MARKET BENEFITS:
• This report provides an extensive analysis of the current and emerging market trends and dynamics in the global veterinary vaccines market.
• Geographically, the veterinary vaccines are analyzed based on various regions such as North America, Europe, Asia-Pacific and LAMEA.
• This study evaluating competitive landscape and value chain has been taken into account to help in understanding the competitive environment across the geographies.
• Comprehensive analysis of factors that drive and restrict the growth of the global veterinary vaccines market is provided. For instance, increasing incidence of zoonotic disease and rising expenditure on animal health drives the market growth while cost of pet care and storage issues forms the restraints of market.
• An in-depth analysis of current research and clinical developments within veterinary vaccines market is provided with key market dynamic factors that helps in understanding the behaviour of the market.
• This report provides the quantitative analysis of the current market and estimations through 2014-2022, which assists in identifying the prevailing market opportunities.
• Key market players within the veterinary vaccines market are profiled in this report and their strategies are analysed thoroughly, which helps in understanding competitive outlook of global veterinary products.
VETERINARY/ANIMAL VACCINES MARKET SEGMENTS:
• Livestock Vaccines
• Companion Animal Vaccines
• Porcine Vaccines
• Equine Vaccines
• Poultry Vaccines
• Aquaculture Vaccines
• Other Animal Vaccines
• Inactivated Vaccines
• Live Attenuated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• DNA Vaccines
• Conjugate Vaccines
• Poultry Diseases
• Companion Animal Disease
• Livestock Diseases
• Aquaculture Diseases
• Other Diseases
1. North America
• Middle East
• South Africa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Veterinary/Animal Vaccines Market Report Competition by Manufacturers, Type and Application, Growth and Opportunities 2026 here
News-ID: 1776376 • Views: 257
More Releases from Allied Market Research
North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently
More Releases for Vaccine
Tetanus Toxoid Vaccine Market
The report for Global Tetanus Toxoid Vaccine Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. Market Highlights: Tetanus is an infectious disease caused by Clostridium tetani characterized by muscle spasms. The spasms may be very severe and even cause bone
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the
Vaccine Market Demand is Increasing
U.S. Vaccine Market: Snapshot The overall vaccine industry has strengthened itself in terms of its growth rate, with a relatively higher growth rate than most other healthcare market segments. Vaccination has been an invaluable addition to better public health, and has helped millions of children, adults and animals from deadly diseases. The CDC stated in a report that diseases such as diphtheria, polio, and smallpox have been fully eliminated, while measles,
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Peanut Allergy Vaccine Market
Allergies are medical conditions caused primarily by hypersensitivity of the immune system to some external stimulus. Allergy may cause anaphylaxis—a medical condition that can cause irritation of the skin, swelling of throat, shortness of breath, and in some cases, death. Allergies are caused by various allergens such as pollen grains, or certain foods such as peanuts. Vaccination is the process of administering antigenic material or a vaccine to stimulate one’s
Shingles Vaccine Market
The shingles vaccine market revenue is expected to grow at a robust rate over the forecast period. Shingles, also known as herpes zoster, is a viral infection that affects the cranial nerves that originate in the brain. It is caused by the varicella zoster virus, the same virus that also cases chicken pox. The virus can stay dormant for many years in the human body. Therefore, anyone who has had